Yahoo Web Search

Search results

    • Is It Too Late to Buy Viking Therapeutics Stock?

      The Motley Fool via AOL· 2 days ago

      Novo Nordisk and Eli Lilly are both competing in the obesity market with their medicines Wegovy and Zepbound. More importantly, they reached the market long before Viking.

  1. Related searches

    fda obesity drug